19:50 EDT Lyell Immunopharma (LYEL) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LYEL:
- Lyell Immunopharma Announces 1-for-20 Reverse Stock Split
- Lyell Immunopharma Stockholders Approve Key Proposals
- Lyell Immunopharma Advances CAR T-Cell Therapy Pipeline
- LYEL Earnings this Week: How Will it Perform?
- Cautious Hold Rating on Lyell Immunopharma Amid Promising Developments and Competitive Challenges